Kawai M, Takada M, Nakayama T, Masuda N, et al. Patient characteristics, treatment patterns, and outcomes of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer patients prescribed cyclin-dependent kinase 4 and 6 inhibitors: large-scale data analysis Breast Cancer Res Treat 2022 Nov 21. doi: 10.1007/s10549-022-06816.
PMID: 36414795